BIIB logo

Biogen (BIIB) Cash from investing

annual CFI:

-$799.20M+$3.30B(+80.51%)
December 31, 2024

Summary

  • As of today (June 7, 2025), BIIB annual cash flow from investing activities is -$799.20 million, with the most recent change of +$3.30 billion (+80.51%) on December 31, 2024.
  • During the last 3 years, BIIB annual CFI has fallen by -$235.50 million (-41.78%).
  • BIIB annual CFI is now -150.69% below its all-time high of $1.58 billion, reached on December 31, 2022.

Performance

BIIB Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

quarterly CFI:

-$47.30M-$28.70M(-154.30%)
March 31, 2025

Summary

  • As of today (June 7, 2025), BIIB quarterly cash flow from investing activities is -$47.30 million, with the most recent change of -$28.70 million (-154.30%) on March 31, 2025.
  • Over the past year, BIIB quarterly CFI has increased by +$18.70 million (+28.33%).
  • BIIB quarterly CFI is now -102.83% below its all-time high of $1.67 billion, reached on September 30, 2022.

Performance

BIIB quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

TTM CFI:

-$780.50M+$18.70M(+2.34%)
March 31, 2025

Summary

  • As of today (June 7, 2025), BIIB TTM cash flow from investing activities is -$780.50 million, with the most recent change of +$18.70 million (+2.34%) on March 31, 2025.
  • Over the past year, BIIB TTM CFI has increased by +$2.43 billion (+75.72%).
  • BIIB TTM CFI is now -148.63% below its all-time high of $1.60 billion, reached on September 30, 2022.

Performance

BIIB TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BIIB Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+80.5%+28.3%+75.7%
3 y3 years-41.8%+92.7%+31.9%
5 y5 years-269.9%-110.7%-215.7%

BIIB Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-150.7%+80.5%-102.8%+97.3%-148.6%+81.0%
5 y5-year-150.7%+80.5%-102.8%+97.3%-148.6%+81.0%
alltimeall time-150.7%+82.5%-102.8%+97.4%-148.6%+85.1%

BIIB Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$47.30M(+154.3%)
-$780.50M(-2.3%)
Dec 2024
-$799.20M(-80.5%)
-$18.60M(-98.4%)
-$799.20M(-44.2%)
Sep 2024
-
-$1.18B(-353.2%)
-$1.43B(-28.1%)
Jun 2024
-
$466.50M(-806.8%)
-$1.99B(-38.0%)
Mar 2024
-
-$66.00M(-89.9%)
-$3.21B(-21.6%)
Dec 2023
-$4.10B(-360.1%)
-$652.30M(-62.6%)
-$4.10B(+14.2%)
Sep 2023
-
-$1.74B(+131.2%)
-$3.59B(+1946.6%)
Jun 2023
-
-$753.50M(-20.9%)
-$175.40M(-113.8%)
Mar 2023
-
-$953.00M(+575.4%)
$1.27B(-19.3%)
Dec 2022
$1.58B(-379.7%)
-$141.10M(-108.4%)
$1.58B(-1.8%)
Sep 2022
-
$1.67B(+141.1%)
$1.60B(-633.6%)
Jun 2022
-
$693.50M(-207.0%)
-$300.80M(-73.8%)
Mar 2022
-
-$648.00M(+475.0%)
-$1.15B(+103.5%)
Dec 2021
-$563.70M(-7.4%)
-$112.70M(-51.8%)
-$563.70M(-8.7%)
Sep 2021
-
-$233.60M(+53.0%)
-$617.40M(+41.5%)
Jun 2021
-
-$152.70M(+136.0%)
-$436.20M(-60.9%)
Mar 2021
-
-$64.70M(-61.1%)
-$1.12B(+83.4%)
Dec 2020
-$608.60M(-229.4%)
-$166.40M(+217.6%)
-$608.60M(-328.6%)
Sep 2020
-
-$52.40M(-93.7%)
$266.20M(-662.8%)
Jun 2020
-
-$832.70M(-288.0%)
-$47.30M(-107.0%)
Mar 2020
-
$442.90M(-37.5%)
$674.60M(+43.4%)
Dec 2019
$470.50M(-123.0%)
$708.40M(-293.6%)
$470.50M(-125.3%)
Sep 2019
-
-$365.90M(+230.2%)
-$1.86B(-12.0%)
Jun 2019
-
-$110.80M(-146.4%)
-$2.12B(-32.9%)
Mar 2019
-
$238.80M(-114.7%)
-$3.15B(+54.1%)
Dec 2018
-$2.05B(-30.9%)
-$1.63B(+162.5%)
-$2.05B(+71.9%)
Sep 2018
-
-$619.10M(-46.1%)
-$1.19B(-34.5%)
Jun 2018
-
-$1.15B(-185.3%)
-$1.82B(+108.4%)
Mar 2018
-
$1.35B(-275.0%)
-$872.30M(-70.6%)
Dec 2017
-$2.96B(+19.2%)
-$769.50M(-38.3%)
-$2.96B(+6.8%)
Sep 2017
-
-$1.25B(+515.8%)
-$2.78B(+86.0%)
Jun 2017
-
-$202.50M(-72.8%)
-$1.49B(-26.3%)
Mar 2017
-
-$744.20M(+27.9%)
-$2.03B(-18.5%)
Dec 2016
-$2.48B(-45.4%)
-$581.70M(-1706.9%)
-$2.48B(-33.0%)
Sep 2016
-
$36.20M(-104.9%)
-$3.71B(-21.7%)
Jun 2016
-
-$736.10M(-38.8%)
-$4.74B(-9.8%)
Mar 2016
-
-$1.20B(-33.4%)
-$5.25B(+15.4%)
Dec 2015
-$4.55B(+195.1%)
-$1.81B(+82.6%)
-$4.55B(+45.7%)
Sep 2015
-
-$990.00M(-21.0%)
-$3.12B(+16.8%)
Jun 2015
-
-$1.25B(+149.3%)
-$2.67B(+30.4%)
Mar 2015
-
-$502.80M(+32.9%)
-$2.05B(+33.0%)
Dec 2014
-$1.54B(-3.8%)
-$378.30M(-30.0%)
-$1.54B(-17.7%)
Sep 2014
-
-$540.56M(-14.2%)
-$1.87B(+13.0%)
Jun 2014
-
-$630.13M(<-9900.0%)
-$1.66B(-5.5%)
Mar 2014
-
$5.99M(-100.8%)
-$1.75B(+9.3%)
Dec 2013
-$1.60B(+68.9%)
-$710.01M(+118.9%)
-$1.60B(+26.3%)
Sep 2013
-
-$324.39M(-55.3%)
-$1.27B(-13.5%)
Jun 2013
-
-$726.24M(-565.7%)
-$1.47B(+84.7%)
Mar 2013
-
$155.94M(-141.5%)
-$795.02M(-16.3%)
Dec 2012
-$950.34M(-42.4%)
-$375.45M(-28.1%)
-$950.34M(-1.5%)
Sep 2012
-
-$522.39M(+883.5%)
-$964.42M(-6.3%)
Jun 2012
-
-$53.12M(-8694.8%)
-$1.03B(-32.4%)
Mar 2012
-
$618.00K(-100.2%)
-$1.52B(-7.7%)
Dec 2011
-$1.65B(-577.9%)
-$389.53M(-33.7%)
-$1.65B(-7.3%)
Sep 2011
-
-$587.18M(+7.4%)
-$1.78B(+41.0%)
Jun 2011
-
-$546.79M(+331.2%)
-$1.26B(+3943.8%)
Mar 2011
-
-$126.80M(-75.6%)
-$31.21M(-109.0%)
Dec 2010
$345.32M(-187.4%)
-$518.62M(+643.5%)
$345.32M(-72.3%)
Sep 2010
-
-$69.75M(-110.2%)
$1.25B(+48.1%)
Jun 2010
-
$683.96M(+173.9%)
$841.89M(-1671.0%)
Mar 2010
-
$249.74M(-34.7%)
-$53.59M(-86.4%)
Dec 2009
-$395.03M(+8.0%)
$382.62M(-180.6%)
-$395.03M(-68.2%)
Sep 2009
-
-$474.43M(+124.3%)
-$1.24B(+43.2%)
Jun 2009
-
-$211.51M(+130.6%)
-$868.45M(-4.3%)
Mar 2009
-
-$91.71M(-80.3%)
-$907.16M(+147.9%)
Dec 2008
-$365.87M(+27.7%)
-$465.76M(+368.2%)
-$365.87M(-29.2%)
Sep 2008
-
-$99.47M(-60.2%)
-$516.75M(+6.8%)
Jun 2008
-
-$250.22M(-155.7%)
-$483.93M(-246.5%)
Mar 2008
-
$449.58M(-172.9%)
$330.39M(-215.3%)
Dec 2007
-$286.57M
-$616.63M(+825.2%)
-$286.57M(-207.6%)
Sep 2007
-
-$66.65M(-111.8%)
$266.38M(-41.4%)
DateAnnualQuarterlyTTM
Jun 2007
-
$564.09M(-437.0%)
$454.52M(-191.8%)
Mar 2007
-
-$167.38M(+162.9%)
-$494.94M(-17.5%)
Dec 2006
-$599.77M(-243.6%)
-$63.68M(-152.4%)
-$599.77M(-1.2%)
Sep 2006
-
$121.49M(-131.5%)
-$607.04M(-51.9%)
Jun 2006
-
-$385.37M(+41.6%)
-$1.26B(-940.5%)
Mar 2006
-
-$272.21M(+283.7%)
$150.24M(-64.0%)
Dec 2005
$417.74M(-209.2%)
-$70.94M(-86.7%)
$417.74M(+44.6%)
Sep 2005
-
-$534.29M(-152.0%)
$288.89M(-56.0%)
Jun 2005
-
$1.03B(<-9900.0%)
$657.26M(-1022.7%)
Mar 2005
-
-$4.71M(-97.6%)
-$71.23M(-81.4%)
Dec 2004
-$382.43M(+49.1%)
-$199.79M(+20.4%)
-$382.43M(+55.8%)
Sep 2004
-
-$165.93M(-155.5%)
-$245.44M(+163.7%)
Jun 2004
-
$299.20M(-194.7%)
-$93.07M(-80.5%)
Mar 2004
-
-$315.91M(+403.0%)
-$478.00M(+86.4%)
Dec 2003
-$256.43M(-69.4%)
-$62.80M(+363.2%)
-$256.43M(-69.9%)
Sep 2003
-
-$13.56M(-84.2%)
-$851.29M(-3.9%)
Jun 2003
-
-$85.73M(-9.1%)
-$886.13M(-2.8%)
Mar 2003
-
-$94.34M(-85.7%)
-$911.30M(+8.6%)
Dec 2002
-$839.15M(+231.4%)
-$657.66M(+1258.9%)
-$839.15M(+268.4%)
Sep 2002
-
-$48.40M(-56.4%)
-$227.78M(-8.1%)
Jun 2002
-
-$110.90M(+399.5%)
-$247.99M(+53.8%)
Mar 2002
-
-$22.20M(-52.0%)
-$161.22M(-36.3%)
Dec 2001
-$253.18M(+140.0%)
-$46.29M(-32.5%)
-$253.18M(-6.9%)
Sep 2001
-
-$68.61M(+184.3%)
-$271.99M(-8.0%)
Jun 2001
-
-$24.13M(-78.9%)
-$295.75M(-4.4%)
Mar 2001
-
-$114.16M(+75.4%)
-$309.21M(+193.1%)
Dec 2000
-$105.49M(-49.8%)
-$65.09M(-29.5%)
-$105.49M(+15.4%)
Sep 2000
-
-$92.38M(+145.8%)
-$91.38M(+54.1%)
Jun 2000
-
-$37.58M(-142.0%)
-$59.30M(-24.0%)
Mar 2000
-
$89.56M(-275.7%)
-$78.02M(-62.9%)
Dec 1999
-$210.08M(+32.4%)
-$50.98M(-15.5%)
-$210.08M(-15.5%)
Sep 1999
-
-$60.30M(+7.1%)
-$248.68M(+14.0%)
Jun 1999
-
-$56.30M(+32.5%)
-$218.18M(+30.9%)
Mar 1999
-
-$42.50M(-52.6%)
-$166.68M(+5.0%)
Dec 1998
-$158.68M(+2.2%)
-$89.58M(+200.6%)
-$158.68M(+42.6%)
Sep 1998
-
-$29.80M(+520.8%)
-$111.30M(-21.8%)
Jun 1998
-
-$4.80M(-86.1%)
-$142.30M(-20.9%)
Mar 1998
-
-$34.50M(-18.3%)
-$179.90M(+15.9%)
Dec 1997
-$155.20M(+89.2%)
-$42.20M(-30.6%)
-$155.20M(-14.6%)
Sep 1997
-
-$60.80M(+43.4%)
-$181.65M(+39.9%)
Jun 1997
-
-$42.40M(+332.7%)
-$129.85M(+71.6%)
Mar 1997
-
-$9.80M(-85.7%)
-$75.65M(-7.8%)
Dec 1996
-$82.05M(-11.1%)
-$68.65M(+662.8%)
-$82.05M(+45.2%)
Sep 1996
-
-$9.00M(-176.3%)
-$56.51M(-11.2%)
Jun 1996
-
$11.80M(-172.8%)
-$63.61M(-33.5%)
Mar 1996
-
-$16.20M(-62.4%)
-$95.71M(+3.7%)
Dec 1995
-$92.31M(+31.3%)
-$43.11M(+167.8%)
-$92.31M(+70.0%)
Sep 1995
-
-$16.10M(-20.7%)
-$54.30M(+108.9%)
Jun 1995
-
-$20.30M(+58.6%)
-$26.00M(+2.4%)
Mar 1995
-
-$12.80M(+151.2%)
-$25.39M(-63.9%)
Dec 1994
-$70.30M(+5.4%)
-$5.09M(-141.8%)
-$70.30M(-9.1%)
Sep 1994
-
$12.20M(-161.9%)
-$77.30M(-24.2%)
Jun 1994
-
-$19.70M(-65.9%)
-$102.00M(+49.8%)
Mar 1994
-
-$57.70M(+376.9%)
-$68.10M(+2.1%)
Dec 1993
-$66.70M(+179.1%)
-$12.10M(-3.2%)
-$66.70M(-16.1%)
Sep 1993
-
-$12.50M(-188.0%)
-$79.50M(+90.2%)
Jun 1993
-
$14.20M(-125.2%)
-$41.80M(-26.7%)
Mar 1993
-
-$56.30M(+126.1%)
-$57.00M(+138.5%)
Dec 1992
-$23.90M(-50.5%)
-$24.90M(-198.8%)
-$23.90M(-53.5%)
Sep 1992
-
$25.20M(-2620.0%)
-$51.40M(-16.4%)
Jun 1992
-
-$1.00M(-95.7%)
-$61.50M(-16.9%)
Mar 1992
-
-$23.20M(-55.7%)
-$74.00M(+53.2%)
Dec 1991
-$48.30M(+63.7%)
-$52.40M(-447.0%)
-$48.30M(>+9900.0%)
Sep 1991
-
$15.10M(-211.9%)
-$200.00K(-99.0%)
Jun 1991
-
-$13.50M(-640.0%)
-$21.00M(+96.3%)
Mar 1991
-
$2.50M(-158.1%)
-$10.70M(-63.7%)
Dec 1990
-$29.50M(-42.0%)
-$4.30M(-24.6%)
-$29.50M(+17.1%)
Sep 1990
-
-$5.70M(+78.1%)
-$25.20M(+29.2%)
Jun 1990
-
-$3.20M(-80.4%)
-$19.50M(+19.6%)
Mar 1990
-
-$16.30M
-$16.30M
Dec 1989
-$50.90M
-
-

FAQ

  • What is Biogen annual cash flow from investing activities?
  • What is the all time high annual CFI for Biogen?
  • What is Biogen annual CFI year-on-year change?
  • What is Biogen quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Biogen?
  • What is Biogen quarterly CFI year-on-year change?
  • What is Biogen TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Biogen?
  • What is Biogen TTM CFI year-on-year change?

What is Biogen annual cash flow from investing activities?

The current annual CFI of BIIB is -$799.20M

What is the all time high annual CFI for Biogen?

Biogen all-time high annual cash flow from investing activities is $1.58B

What is Biogen annual CFI year-on-year change?

Over the past year, BIIB annual cash flow from investing activities has changed by +$3.30B (+80.51%)

What is Biogen quarterly cash flow from investing activities?

The current quarterly CFI of BIIB is -$47.30M

What is the all time high quarterly CFI for Biogen?

Biogen all-time high quarterly cash flow from investing activities is $1.67B

What is Biogen quarterly CFI year-on-year change?

Over the past year, BIIB quarterly cash flow from investing activities has changed by +$18.70M (+28.33%)

What is Biogen TTM cash flow from investing activities?

The current TTM CFI of BIIB is -$780.50M

What is the all time high TTM CFI for Biogen?

Biogen all-time high TTM cash flow from investing activities is $1.60B

What is Biogen TTM CFI year-on-year change?

Over the past year, BIIB TTM cash flow from investing activities has changed by +$2.43B (+75.72%)
On this page